Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study
- PMID: 35837564
- PMCID: PMC9233968
- DOI: 10.5847/wjem.j.1920-8642.2022.062
Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study
Conflict of interest statement
Conflicts of interests: The authors have no competing interests.
Similar articles
-
Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.Front Oncol. 2020 Oct 28;10:538779. doi: 10.3389/fonc.2020.538779. eCollection 2020. Front Oncol. 2020. Retraction in: Front Oncol. 2021 Jun 03;11:709636. doi: 10.3389/fonc.2021.709636. PMID: 33194600 Free PMC article. Retracted.
-
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.J Oncol Pharm Pract. 2018 Jun;24(4):299-308. doi: 10.1177/1078155217701291. Epub 2017 Mar 29. J Oncol Pharm Pract. 2018. PMID: 28355969
-
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.Pediatr Blood Cancer. 2005 Jan;44(1):95-7. doi: 10.1002/pbc.20187. Pediatr Blood Cancer. 2005. PMID: 15368548
-
Asparaginase-associated pancreatitis in children.Br J Haematol. 2012 Oct;159(1):18-27. doi: 10.1111/bjh.12016. Epub 2012 Aug 22. Br J Haematol. 2012. PMID: 22909259 Review.
-
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia .Clin J Oncol Nurs. 2017 Oct 1;21(5):E248-E259. doi: 10.1188/17.CJON.E248-E259. Clin J Oncol Nurs. 2017. PMID: 28945721 Review.
Cited by
-
Asparaginase-associated Pancreatitis Complicated by Pancreatic Fluid Collection Treated with Endoscopic Cistogastrostomy in Pediatric Acute Lymphoblastic Leukemia: A Case Report and Systematic Review of the Literature.Clin Hematol Int. 2023 Dec 20;5(4):51-61. doi: 10.46989/001c.90958. eCollection 2023. Clin Hematol Int. 2023. PMID: 38817959 Free PMC article.
-
Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.Front Oncol. 2025 Jun 26;15:1606261. doi: 10.3389/fonc.2025.1606261. eCollection 2025. Front Oncol. 2025. PMID: 40641923 Free PMC article.
References
-
- Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol. 2007;61(3):208–21. - PubMed
-
- Ettinger LJ, Ettinger AG, Avramis VI, Gaynon PS. Acute lymphoblastic leukaemia:a guide to asparaginase and pegaspargase therapy. BioDrugs. 1997;7(1):30–9. - PubMed
-
- Sallan SE, Gelber RD, Kimball V, Donnelly M, Cohen HJ. More is better!Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials. Haematol Blood Transfus. 1990;33(4):459–66. - PubMed
-
- Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia:results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211–8. - PubMed
-
- Keating MJ, Holmes R, Lerner S, Ho DH. L-asparaginase and PEG asparaginase—past, present, and future. Leuk Lymphoma. 1993;10(Suppl):153–7. - PubMed
LinkOut - more resources
Full Text Sources